Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.190
0.00 (0.00%)
Feb 20, 2025, 1:34 PM EST
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 501.69K CAD in the quarter ending November 30, 2024, with 114.57% growth. This brings the company's revenue in the last twelve months to 1.61M, up 53.98% year-over-year. In the fiscal year ending February 29, 2024, Rapid Dose Therapeutics had annual revenue of 1.02M with 42.06% growth.
Revenue (ttm)
1.61M
Revenue Growth
+53.98%
P/S Ratio
14.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
24.40M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.51B |
| Curaleaf Holdings | 1.83B |
| WELL Health Technologies | 957.69M |
| dentalcorp Holdings | 1.51B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.58B |
| Cronos Group | 150.26M |
| Extendicare | 1.42B |